TEST BANK 3
Pharmacotherapeutics3for3Advanced3Practice3Nurse3Prescribers,36th3Edition
Author:3Teri3Moser3Woo3and3Wendy3L.3Wright
, TABLE3OF3CONTENT
Chapter31.3The3Role3of3the3Advanced3Practice3Nurse3as3Prescriber.................................................................... 4
Chapter32.3Review3of3Basic3Principles3of3Pharmacology .................................................................................... 5
Chapter33.3Rational3Drug3Selection .................................................................................................................... 11
Chapter34.3Legal3and3Professional3Issues3in3Prescribing ................................................................................... 14
Chapter35.3Adverse3Drug3Reactions ................................................................................................................... 16
Chapter36.3An3Introduction3to3Pharmacogenomics............................................................................................. 19
Chapter37.3Nutrition3and3Nutraceuticals ............................................................................................................. 22
Chapter38.3Herbal3Therapies ............................................................................................................................... 28
Chapter39.3Cannabis ............................................................................................................................................ 31
Chapter310.3Pharmacoeconomics ........................................................................................................................ 35
Chapter311.3Drugs3Affecting3the3Autonomic3Nervous3System .......................................................................... 38
Chapter312.3Drugs3Affecting3the3Central3Nervous3System ................................................................................ 45
Chapter313.3Drugs3Affecting3the3Cardiovascular3and3Renal3Systems ............................................................... 53
Chapter314.3Drugs3Affecting3the3Respiratory3System ........................................................................................ 61
Chapter315.3Drugs3Affecting3the3Hematological3System ................................................................................... 65
Chapter316.3Drugs3Affecting3the3Immune3System:3Vaccines3and3Immunoglobulins ........................................ 69
Chapter317.3Drugs3Affecting3the3Immune3System:3Immunomodulators ............................................................ 75
Chapter318.3Drugs3Affecting3the3Gastrointestinal3System ................................................................................. 77
Chapter319.3Drugs3Affecting3the3Endocrine3System:3Pancreatic3Hormones3and3Antidiabetic3Drugs................ 80
Chapter320.3Drugs3Affecting3the3Endocrine3System:3Pituitary,3Thyroid,3and3Adrenal3Drugs .......................... 83
Chapter321.3Drugs3Affecting3the3Reproductive3System ..................................................................................... 86
Chapter322.3Drugs3Affecting3the3Bones3and3Joints ............................................................................................ 92
Chapter323.3Drugs3Affecting3the3Integumentary3System ................................................................................... 96
Chapter324.3Drugs3Used3to3Treat3Bacterial3Infections ..................................................................................... 101
Chapter325.3Drugs3Used3to3Treat3Viral,3Fungal,3and3Protozoal3Infections ...................................................... 105
Chapter326.3Drugs3Used3to3Treat3Inflammatory3Processes .............................................................................. 108
Chapter327.3Drugs3Used3to3Treat3Eye3and3Ear3Disorders ................................................................................ 111
Chapter328.3Anemia .......................................................................................................................................... 113
Chapter329.3Anxiety3and3Depression ................................................................................................................ 116
Chapter330.3Attention3Deficit-Hyperactivity3Disorder ..................................................................................... 120
Chapter331.3Asthma3and3Allergy ...................................................................................................................... 122
Chapter332.3Chronic3Obstructive3Pulmonary3Disease ...................................................................................... 125
Chapter333.3Contraception ................................................................................................................................ 127
Chapter334.3COVID-19:3Acute3and3Chronic .................................................................................................... 130
Chapter335.3Dermatological3Conditions ........................................................................................................... 134
Chapter336.3Diabetes3Management ................................................................................................................... 138
Chapter337.3Gastroesophageal3Reflux3and3Peptic3Ulcer3Disease ..................................................................... 146
Chapter338.3Headaches...................................................................................................................................... 149
Chapter339.3Heart3Failure ................................................................................................................................. 153
Chapter340.3HIV3Disease3and3Acquired3Immunodeficiency3Syndrome .......................................................... 158
Chapter341.3Menopausal3Hormone3Therapy..................................................................................................... 161
,Chapter342.3Hyperlipidemia .............................................................................................................................. 164
Chapter343.3Hypertension ................................................................................................................................. 169
Chapter344.3Hyperthyroidism3and3Hypothyroidism ......................................................................................... 174
Chapter345.3Obesity .......................................................................................................................................... 177
Chapter346.3Pain3Management:3Acute3and3Chronic3Pain................................................................................. 181
Chapter347.3Pneumonia ..................................................................................................................................... 185
Chapter348.3Sexually3Transmitted3Diseases3and3Vaginitis............................................................................... 187
Chapter349.3Substance3Use3Disorders............................................................................................................... 190
Chapter350.3Tuberculosis .................................................................................................................................. 195
Chapter351.3Upper3Respiratory3Tract3Infection,3Pharyngitis,3Sinusitis,3Otitis3Media,3and3Otitis3Externa ....... 197
Chapter352.3Urinary3Tract3Infections ................................................................................................................ 200
Chapter353.3Women3as3Patients ........................................................................................................................ 203
Chapter354.3Men3as3Patients ............................................................................................................................. 207
Chapter355.3Pediatric3Patients ........................................................................................................................... 209
Chapter357.3Geriatric3Patients ........................................................................................................................... 213
, Woo 1
Pharmacotherapeutics3for3APN3Prescribers,36 Ch01
e
Chapter31.3The3Role3of3the3Advanced3Practice3Nurse3as3Prescriber
MULTIPLE3CHOICE
1. Nurse3practitioner3prescriptive3authority3is3regulated3by:
A. The3National3Council3of3State3Boards3of3Nursing
B. The3U.S.3Drug3Enforcement3Administration
C. The3State3Board3of3Nursing3for3each3state
D. The3State3Board3of3Pharmacy
ANS:3 C PTS:3 3 1
2. The3benefits3to3the3patient3of3having3an3advanced3practice3registered3nurse3(APRN)3prescrib
er3include:
A. Nurses3know3more3about3pharmacology3than3other3prescribers3because3they3take3i
t3both3in3their3basic3nursing3program3and3in3their3APRN3program.
B. Nurses3care3for3the3patient3from3a3holistic3approach3and3include3the3patient3i
n3decision-making3regarding3their3care.
C. APRNs3are3less3likely3to3prescribe3narcotics3and3other3controlled3substances.
D. APRNs3are3able3to3prescribe3independently3in3all3states,3whereas3a3physician’
s3assistant3needs3to3have3a3physician3supervising3their3practice.
ANS:3 B PTS:3 3 1
3. Clinical3judgment3in3prescribing3includes:
A. Factoring3in3the3cost3to3the3patient3of3the3medication3prescribed
B. Always3prescribing3the3newest3medication3available3for3the3disease3process
C. Handing3out3drug3samples3to3poor3patients
D. Prescribing3all3generic3medications3to3cut3costs
ANS:3 A PTS:3 3 1
4. The3process3for3choosing3an3effective3drug3for3a3disorder3includes:
A. Asking3the3patient3what3drug3they3think3would3work3best3for3them
B. Consulting3nationally3recognized3guidelines3for3disease3management
C. Prescribing3medications3that3are3available3as3samples3before3writing3a3prescription
D. Following3U.S.3Drug3Enforcement3Administration3guidelines3for3prescribing
ANS:3 B PTS:3 3 1
5. Nonintentional3nonadherence3of3drug3therapy3may3occur3due3to:
A. Belief3that3medication3does3not3work
B. Adverse3drug3reactions
C. Chronic3conditions3that3require3daily3therapy
D. Forgetfulness3or3distraction
ANS:3 D PTS:3 3 1
Pharmacotherapeutics3for3Advanced3Practice3Nurse3Prescribers,36th3Edition
Author:3Teri3Moser3Woo3and3Wendy3L.3Wright
, TABLE3OF3CONTENT
Chapter31.3The3Role3of3the3Advanced3Practice3Nurse3as3Prescriber.................................................................... 4
Chapter32.3Review3of3Basic3Principles3of3Pharmacology .................................................................................... 5
Chapter33.3Rational3Drug3Selection .................................................................................................................... 11
Chapter34.3Legal3and3Professional3Issues3in3Prescribing ................................................................................... 14
Chapter35.3Adverse3Drug3Reactions ................................................................................................................... 16
Chapter36.3An3Introduction3to3Pharmacogenomics............................................................................................. 19
Chapter37.3Nutrition3and3Nutraceuticals ............................................................................................................. 22
Chapter38.3Herbal3Therapies ............................................................................................................................... 28
Chapter39.3Cannabis ............................................................................................................................................ 31
Chapter310.3Pharmacoeconomics ........................................................................................................................ 35
Chapter311.3Drugs3Affecting3the3Autonomic3Nervous3System .......................................................................... 38
Chapter312.3Drugs3Affecting3the3Central3Nervous3System ................................................................................ 45
Chapter313.3Drugs3Affecting3the3Cardiovascular3and3Renal3Systems ............................................................... 53
Chapter314.3Drugs3Affecting3the3Respiratory3System ........................................................................................ 61
Chapter315.3Drugs3Affecting3the3Hematological3System ................................................................................... 65
Chapter316.3Drugs3Affecting3the3Immune3System:3Vaccines3and3Immunoglobulins ........................................ 69
Chapter317.3Drugs3Affecting3the3Immune3System:3Immunomodulators ............................................................ 75
Chapter318.3Drugs3Affecting3the3Gastrointestinal3System ................................................................................. 77
Chapter319.3Drugs3Affecting3the3Endocrine3System:3Pancreatic3Hormones3and3Antidiabetic3Drugs................ 80
Chapter320.3Drugs3Affecting3the3Endocrine3System:3Pituitary,3Thyroid,3and3Adrenal3Drugs .......................... 83
Chapter321.3Drugs3Affecting3the3Reproductive3System ..................................................................................... 86
Chapter322.3Drugs3Affecting3the3Bones3and3Joints ............................................................................................ 92
Chapter323.3Drugs3Affecting3the3Integumentary3System ................................................................................... 96
Chapter324.3Drugs3Used3to3Treat3Bacterial3Infections ..................................................................................... 101
Chapter325.3Drugs3Used3to3Treat3Viral,3Fungal,3and3Protozoal3Infections ...................................................... 105
Chapter326.3Drugs3Used3to3Treat3Inflammatory3Processes .............................................................................. 108
Chapter327.3Drugs3Used3to3Treat3Eye3and3Ear3Disorders ................................................................................ 111
Chapter328.3Anemia .......................................................................................................................................... 113
Chapter329.3Anxiety3and3Depression ................................................................................................................ 116
Chapter330.3Attention3Deficit-Hyperactivity3Disorder ..................................................................................... 120
Chapter331.3Asthma3and3Allergy ...................................................................................................................... 122
Chapter332.3Chronic3Obstructive3Pulmonary3Disease ...................................................................................... 125
Chapter333.3Contraception ................................................................................................................................ 127
Chapter334.3COVID-19:3Acute3and3Chronic .................................................................................................... 130
Chapter335.3Dermatological3Conditions ........................................................................................................... 134
Chapter336.3Diabetes3Management ................................................................................................................... 138
Chapter337.3Gastroesophageal3Reflux3and3Peptic3Ulcer3Disease ..................................................................... 146
Chapter338.3Headaches...................................................................................................................................... 149
Chapter339.3Heart3Failure ................................................................................................................................. 153
Chapter340.3HIV3Disease3and3Acquired3Immunodeficiency3Syndrome .......................................................... 158
Chapter341.3Menopausal3Hormone3Therapy..................................................................................................... 161
,Chapter342.3Hyperlipidemia .............................................................................................................................. 164
Chapter343.3Hypertension ................................................................................................................................. 169
Chapter344.3Hyperthyroidism3and3Hypothyroidism ......................................................................................... 174
Chapter345.3Obesity .......................................................................................................................................... 177
Chapter346.3Pain3Management:3Acute3and3Chronic3Pain................................................................................. 181
Chapter347.3Pneumonia ..................................................................................................................................... 185
Chapter348.3Sexually3Transmitted3Diseases3and3Vaginitis............................................................................... 187
Chapter349.3Substance3Use3Disorders............................................................................................................... 190
Chapter350.3Tuberculosis .................................................................................................................................. 195
Chapter351.3Upper3Respiratory3Tract3Infection,3Pharyngitis,3Sinusitis,3Otitis3Media,3and3Otitis3Externa ....... 197
Chapter352.3Urinary3Tract3Infections ................................................................................................................ 200
Chapter353.3Women3as3Patients ........................................................................................................................ 203
Chapter354.3Men3as3Patients ............................................................................................................................. 207
Chapter355.3Pediatric3Patients ........................................................................................................................... 209
Chapter357.3Geriatric3Patients ........................................................................................................................... 213
, Woo 1
Pharmacotherapeutics3for3APN3Prescribers,36 Ch01
e
Chapter31.3The3Role3of3the3Advanced3Practice3Nurse3as3Prescriber
MULTIPLE3CHOICE
1. Nurse3practitioner3prescriptive3authority3is3regulated3by:
A. The3National3Council3of3State3Boards3of3Nursing
B. The3U.S.3Drug3Enforcement3Administration
C. The3State3Board3of3Nursing3for3each3state
D. The3State3Board3of3Pharmacy
ANS:3 C PTS:3 3 1
2. The3benefits3to3the3patient3of3having3an3advanced3practice3registered3nurse3(APRN)3prescrib
er3include:
A. Nurses3know3more3about3pharmacology3than3other3prescribers3because3they3take3i
t3both3in3their3basic3nursing3program3and3in3their3APRN3program.
B. Nurses3care3for3the3patient3from3a3holistic3approach3and3include3the3patient3i
n3decision-making3regarding3their3care.
C. APRNs3are3less3likely3to3prescribe3narcotics3and3other3controlled3substances.
D. APRNs3are3able3to3prescribe3independently3in3all3states,3whereas3a3physician’
s3assistant3needs3to3have3a3physician3supervising3their3practice.
ANS:3 B PTS:3 3 1
3. Clinical3judgment3in3prescribing3includes:
A. Factoring3in3the3cost3to3the3patient3of3the3medication3prescribed
B. Always3prescribing3the3newest3medication3available3for3the3disease3process
C. Handing3out3drug3samples3to3poor3patients
D. Prescribing3all3generic3medications3to3cut3costs
ANS:3 A PTS:3 3 1
4. The3process3for3choosing3an3effective3drug3for3a3disorder3includes:
A. Asking3the3patient3what3drug3they3think3would3work3best3for3them
B. Consulting3nationally3recognized3guidelines3for3disease3management
C. Prescribing3medications3that3are3available3as3samples3before3writing3a3prescription
D. Following3U.S.3Drug3Enforcement3Administration3guidelines3for3prescribing
ANS:3 B PTS:3 3 1
5. Nonintentional3nonadherence3of3drug3therapy3may3occur3due3to:
A. Belief3that3medication3does3not3work
B. Adverse3drug3reactions
C. Chronic3conditions3that3require3daily3therapy
D. Forgetfulness3or3distraction
ANS:3 D PTS:3 3 1
